Houston Oncology Summit: MD Anderson’s Ferran Prat, VP of industry relations, talks about partnering

Sep 21

Written by Mukul Verma

CFF

ImmunoGenesis Doses First Patient in Clinical Trial of Drug for Advanced Solid Tumors

Cancer Focus Fund Investing $4.5 Million in ImmunoGenesis to Support Drug Trial for Relapsed or Refractory Advanced Solid Tumors